论文部分内容阅读
洋地黄作为心力衰竭(心衰)的主要治疗药物已有200年历史,至今在心衰的药物治疗中仍保持重要地位。但随着心衰病理生理研究的逐步深入,多种利尿剂、血管扩张剂及非洋地黄类正性肌力药物的相继问世,洋地黄在心衰治疗中的地位,受到一定程度的冲击。洋地黄虽然仍是治疗部分心衰患者的首选药物,但并非所有心衰患者的首选药物,也并不对所有心衰患者都有益。在急性心衰患者的治疗中,除少数
Digitalis has been a major therapeutic drug for heart failure (heart failure) for more than 200 years and still plays an important role in the treatment of heart failure. However, with the gradual deepening of pathophysiology of heart failure, multiple diuretics, vasodilators and non-digitalis positive inotropic drugs have come out in succession, digitalis in the treatment of heart failure, to a certain extent, the impact. Although digitalis is still the treatment of some patients with heart failure in the preferred drug, but not all patients with heart failure drug of choice, it is not beneficial to all patients with heart failure. In the treatment of patients with acute heart failure, except a few